Keywords: Arrowhead Research, Alvos Thera, M&S, Peptides platform

Arrowhead takes over Alvos Thera in stock deal

Article | 12 April 2012

Print This

USA-based nano-medicine developer Arrowhead Research Corp (Nasdaq: ARWR) says it has acquired Alvos Therapeutics in a two part stock deal. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in